Immediate and short-term performance of a novel sirolimus-coated balloon during complex percutaneous coronary interventions. The FAtebenefratelli SIrolimus COated-balloon (FASICO) registry

Drug-coated balloons (DCB) currently represent an alternative to drug-eluting stents (DES) for the treatment of in-stent restenosis and they are also variably used for small coronary vessel and bifurcation lesion management. All DCB variably elute paclitaxel as an anti-proliferative drug. The first sirolimus coated balloon (SCB) received the CE mark in 2016, but its clinical performance has not been shown yet.

Source: Cardiovascular Revascularization Medicine - March 24, 2017 Category: Cardiology Authors: Bernardo Cortese, Gaetano di Palma, Roberto A. Latini, Mostafa Elwany, Pedro Silva Orrego, Romano G. Seregni Source Type: research